The MarketWatch News Department was not involved in the creation of this content.-- 2025 revenue of $37.1 million, up 4% year-over-year, and 71% Full-year gross margins -- Enhance ...
This report documents a young female patient with microgranular variant acute promyelocytic leukaemia (APL) harbouring FLT3-ITD mutation who presented with fatigue, fever, gum bleeding and altered ...
Full-year gross margins Enhanced Balance Sheet Flexibility with an Additional $2.5 million Proceeds from Amended Credit Facility in November Implemented Strategic Workforce and Cost Reduction Program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results